End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
160.8 MXN | -.--% | -.--% | -.--% |
Jun. 27 | Hansa Biopharma AB Announces Board Appointments | CI |
May. 31 | Hansa Biopharma Finalizes Patient Randomization for Use of Imlifidase inKidney Transplantation Trial | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
HANSA BIOPHARMA AB | Other Biotechnology & Medical Research | -.--% | -.--% | -.--% | -.--% | - | 296M | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- HNSA Stock
- HNSA N Stock
- Charts Hansa Biopharma AB
- Comparison Chart